Avoro Capital Advisors LLC - 30 Sep 2025 SCHEDULE 13G Report for Structure Therapeutics Inc. Ordinary Shares, par value $0.0001 per share (GPCR)

Filing Manager
Avoro Capital Advisors LLC
Reporting Manager
Avoro Capital Advisors LLC
Security
Structure Therapeutics Inc. Ordinary Shares, par value $0.0001 per share
Symbol
GPCR
Shares outstanding
172,885,554 shares
Disclosed Ownership
16,216,665 shares
Ownership
9.4%
Form type
SCHEDULE 13G
Filing time
14 Nov 2025, 09:01:43 UTC
Date of event
30 Sep 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Avoro Capital Advisors LLC disclosed 9.4% ownership in Structure Therapeutics Inc. Ordinary Shares, par value $0.0001 per share (GPCR) on 30 Sep 2025."

Quick Takeaways

  • Avoro Capital Advisors LLC filed SCHEDULE 13G for Structure Therapeutics Inc. Ordinary Shares, par value $0.0001 per share (GPCR).
  • Disclosed ownership: 9.4%.
  • Date of event: 30 Sep 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Nov 2025, 09:01.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Avoro Capital Advisors LLC 9.4% 16,216,665 16,216,665 0 /s/ Scott Epstein Scott Epstein, Chief Operating Officer & Chief Compliance Officer
Aghazadeh Behzad 9.4% 16,216,665 16,216,665 0 /s/ Behzad Aghazadeh Behzad Aghazadeh, Individually

Sponsored